Pioneering Global Collaboration

Dianne Trauring and Nancy Carpenter lost their mother in 2010 after a long battle with Alzheimer’s disease. Stories like theirs drive Indiana University School of Medicine physicians and scientists to focus on ways to develop new ways to diagnose, treat and ultimately prevent Alzheimer’s disease.

There has never been a more critical or dynamic time for Alzheimer’s research. More than 35 million people worldwide have dementia, a number that is expected to nearly double every 20 years. In the United States alone, an estimated 5.5 million people are suffering from Alzheimer’s disease or related dementias.

IU School of Medicine’s multidisciplinary team of researchers understands that collaboration is key to make real progress. Experts from across the school work hand-in-hand with partners from throughout academia and industry with the goal of ending suffering from Alzheimer’s disease and related dementias.

See Dianne and Nancy’s story

National Leader in Alzheimer’s Research

Beyond conducting leading-edge research in its own laboratories, Indiana University School of Medicine physicians and scientists provide critical expertise to support research underway throughout the country. The federal government has designated IU School of Medicine as the national site that collects blood, DNA, tissue and other samples from tens of thousands of Americans with Alzheimer’s disease, providing a wealth of information for scientists to mine. The school is also developing laboratory models that are used by scientists throughout the country to study genetic contributors to the disease and test potential treatments. And IU School of Medicine is leading a nationwide study of a rare and particularly devastating early-onset form of Alzheimer’s that afflicts patients in the prime of their lives.

 

Working on Prevention and Effective Treatment by 2025

Many Alzheimer investigators and programs at IU School of Medicine are affiliated with the Indiana Alzheimer Disease Center, where resources are shared to support and facilitate research advancements. This center attracts world-class faculty who use advanced technology to lead some of the most robust dementia research in the world in order to achieve the national plan to address Alzheimer’s disease.

The Indiana Alzheimer Disease Center is solely committed to supporting the National Alzheimer’s Project Act (NAPA), an initiative to lead research to prevent and effectively treat Alzheimer disease by 2025. Signed by President Barack Obama, the Act offers a historic opportunity to address the many challenges facing people with Alzheimer’s and their families.

Recruiting Healthy and Affected Participants for Clinical Trials

Successful clinical trials rely on both healthy individuals and people with Alzheimer’s disease to identify symptoms and gene markers that indicate the disease. IU School of Medicine has many active clinical trials. Information on these studies, including who’s needed to help advance these research studies, is available.

Clinical Research

259
Cost of dementia in 2017 to U.S. (in billions of dollars)
30
Number of Years that IU School of Medicine has been leading dementia research
33
Percent of the U.S. seniors who die of Alzheimer's and other dementias
66
Frequency (in seconds) someone in the U.S. develops Alzheimer's disease

Accomplished Faculty Investigators

IU School of Medicine faculty investigators studying Alzheimer's disease receive generous grant awards and international support to advance their studies toward finding solutions. The school is committed to ending the suffering of this disease no matter how long it takes. Through robust training programs and accomplished faculty mentors, the school is developing new researchers specifically trained to discover innovative approaches to improve understanding, diagnosis and treatment of Alzheimer’s disease and other dementias.

Advanced technology driving patient-centered research

Research

Research

IU School of Medicine recruits top global researchers to discover how to prevent and effectively treat Alzheimer disease by 2025.
Clinical Trials

Clinical Trials

The school relies on both healthy individuals and individuals with Alzheimer’s disease to identify symptoms and gene markers that indicate the disease.
Partners

Partners

Most Alzheimer programs collaborate by sharing resources to support and facilitate research at Indiana University and beyond.
News and Events

News and Events

Stay up-to-date on research news and seminars related to Alzheimer’s disease.

Alzheimer’s Training

Indiana University School of Medicine is training the next generation of researchers specifically focused on discovering new ways to increase understanding, diagnosis and treatment of Alzheimer’s disease and other dementias. Outstanding researchers have opportunities here to gain experience working on multidisciplinary studies that involve local, national and international collaborators. Research studies range from genetics and medical neuroscience to medical and molecular genetics and computer science/bioinformatics–and beyond.